Introduction
Acupuncture is an ancient Chinese healing modality with putative therapeutic effects for clinical pain management. However, it is often dismissed by mainstream allopathic medicine due to a paucity of data demonstrating its neurophysiological differentiation from placebo. Functional neuroimaging provides a means to determine which brain networks support acupuncture as well as map the differences between its specific and non-specific neural correlates. It is important to remember that although placebo effects can occur with all forms of medical treatment their neurophysiological basis may differ with the type of treatment being given (Colloca and Benedetti, 2005) . In general, placebo effects are believed to arise from unconscious conditioning (Voudouris et al., 1990; Wickramasekera, 1999) , changes in (verbal) expectancy (Montgomery and Kirsch, 1997) , and/or differences in practitioner suggestion and patient suggestibility (Wickramasekera, 1999; De Pascalis et al., 2002) . However, these effects likely overlap and there is strong evidence that expectancy is the major contributor to increasing treatment efficacy (Montgomery and Kirsch, 1997). Thus, acupuncture specific brain activity must at the least be differentiated from non-specific activity supporting subject expectations for treatment.
Therapeutic acupuncture is at least partially mediated by endogenous anti-nociceptive brain networks
Neuroimaging data demonstrate that acupuncture recruits a distributed cortical and subcortical brain network. Although some evidence exists for specificity of brain response to acupoint vs. non-acupoint treatment (Wu et al., 2002) as well as Traditional Chinese Medicine (TCM) applications (Cho et al., 1998; Li et al., 2003) , clear acupoint specificity has been difficult to replicate (Gareus et al., 2002; Cho et al., 2006) and many points may elicit overlapping responses within multiple brain areas. Indeed, it is highly likely that acupuncture elicits a common, distributed network of brain regions and that the neurophysiological effects related to acupoint specificity are subtle as well as subject and/or state dependent.
Data from animal research provide strong support for the hypothesis that therapeutic acupuncture is mediated, at least partially, by opioidergic and/or monoaminergic neurotransmission involving the brainstem, thalamus, and/or hypothalamic as well as pituitary action (Pomeranz and Chiu, 1976; Zhou et al., 1981; Stux and Hammerschlag, 2001) . Afferent spinal gating and, in the case of painful needling, stress induced analgesia and diffuse noxious inhibitory control (DNIC) may support short-term analgesic effects (Carlsson, 2002) . Human neuroimaging data demonstrate that acupuncture stimulation modulates a wide network of brain regions including the primary somatosensory (SI), secondary somatosensory (SII), anterior cingulate (ACC), prefrontal (PFC), and insular cortices, amygdala, hippocampus, hypothalamus, periaquaductal gray (PAG), and cerebellar vermis (Wu et al., 1999; Hui et al., 2000 Hui et al., , 2005 Zhang et al., 2003; Liu et al., 2004; Yoo et al., 2004; Napadow et al., 2005) . Furthermore, many investigators have noted fMRI deactivation in limbic regions when contrasting acupuncture needle stimulation with non-stimulation baseline (Fig. 1) , attributing this phenomenon to decreased neuronal activity (Wu et al., 1999; Hui et al., 2000; Zhang et al., 2003;  
